ABBV vs MRK — stock comparison
AbbVie Inc. (ABBV) vs Merck & Co., Inc. (MRK): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, ABBV grades higher (B 63 vs C 48). Not investment advice.
1-year price performance — higher line = stronger return
■ ABBV +19.8%■ MRK +63.3%Past year, both rebased to 100
| ABBV | MRK | |
|---|---|---|
| Traddx grade | B (63) | C (48) |
| Price | $267.40 | $140.98 |
| Today | 0.62% | 1.03% |
| P/E | 75.50 | 77.50 |
| Net margin | 9.80% | 7.00% |
| Revenue (TTM) | $64,386.00M | $65,975.00M |
| Debt / equity | — | — |
| 52-week high | $269.39 | $156.92 |
| 52-week low | $190.75 | $82.01 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open ABBV live → Open MRK live →